Discover the signs of psoriatic arthritis, from joint pain and skin changes to nail damage and fatigue, plus the latest treatment options for this condition.

Medically reviewed by Stella Bard, MD Psoriatic arthritis (PsA) is a chronic (long-term) condition that includes symptoms of ...

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Initially disclosing a diagnosis of rheumatoid arthritis, he later revealed that he actually suffers from psoriatic arthritis - a chronic condition characterised by joint pain, swelling and ...

Adam also apologised to his followers for having not been "very vocal" about his experience with arthritis lately. He told them in the recent post on Instagram: "[I'm] just struggling and trying ...

Pain, stiffness, and other symptoms stem from chronic inflammation caused by an immune system that’s mistakenly attacking the body’s healthy tissues as if they were infectious agents. Some types of ...

Among a large cohort of young adults with psoriatic arthritis, 38.8% exhibited radiographic evidence of degenerative disc disease. Researchers in Canada conducted a retrospective cohort study to ...

We're expecting another mild and dry day today, Tuesday, as high pressure continues to dominate our weather. Expect mostly sunny skies with only a bit of thin cloud cover at times. High temperatures ...

There has been no rapid deterioration in her health or her symptoms because, she believes, she was put on medication quickly. "I feel a little more shaky inside, but I haven't got a tremor ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

for active psoriatic arthritis (PsA). The APEX trial met both its primary and major secondary endpoints at 24 weeks in adults with active PsA. The double-blind, multi-centre trial showed that the ...